OOIR: Observatory of International Research

Papers

(The TQCC of Heart Failure Reviews is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Creatine deficiency and heart failure	243
Prognostic value of left ventricular global longitudinal strain in mitral regurgitation: a systematic review	69
Can mechanical circulatory support be an effective treatment for HFpEF patients?	62
Effects of bromocriptine in peripartum cardiomyopathy: a systematic review and meta-analysis	45
Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction	41
Alterations of sodium-hydrogen exchanger 1 function in response to SGLT2 inhibitors: what is the evidence?	40
Meta-analysis addressing the impact of cardiovascular-acting medication on peak oxygen uptake of patients with HFpEF	38
An updated systematic review on heart failure treatments for patients with renal impairment: the tide is not turning	36
Ambulatory factors influencing pulmonary artery pressure waveforms and implications for clinical practice	36
Lung ultrasound–guided management to reduce hospitalization in chronic heart failure: a systematic review and meta-analysis	33
Social and environmental risks as contributors to the clinical course of heart failure	32
Fibrosis in hypertrophic cardiomyopathy: role of novel echo techniques and multi-modality imaging assessment	32
Deciphering hypertrophic cardiomyopathy with electrocardiography	31
Trends and complications associated with acute new-onset heart failure: a National Readmissions Database–based cohort study	30
Cardiovascular disease associated with methamphetamine use: a review	29
Imaging techniques for the assessment of adverse cardiac remodeling in metabolic syndrome	28
Comprehensive approach to cardiac amyloidosis care: considerations in starting an amyloidosis program	27
Left ventricular hypertrophy and sudden cardiac death	27
Detection of myocardial fibrosis by speckle-tracking echocardiography: from prediction to clinical applications	24
Heart–lung interactions in COVID-19: prognostic impact and usefulness of bedside echocardiography for monitoring of the right ventricle involvement	24
A systematic review exploring the significance of measuring epicardial fat thickness in correlation to B-type natriuretic peptide levels as prognostic and diagnostic markers in patients with or at ris	24
Advanced airway management and respiratory care in decompensated pulmonary hypertension	24
The right ventricular involvement in dilated cardiomyopathy: prevalence and prognostic implications of the often-neglected child	23
Severe low-gradient aortic stenosis: impact of inadequate left ventricular responses to high afterload on diagnosis and therapeutic decision-making	23
Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure	22

Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid	22
Editorial Expression of Concern: Water and sodium in heart failure: a spotlight on congestion	21
Atrial fibrillation-induced tachycardiomyopathy and heart failure: an underappreciated and elusive condition	20
Cardiovascular magnetic resonance for suspected cardiac amyloidosis: where are we now?	19
The use of diflunisal for transthyretin cardiac amyloidosis: a review	19
Correction to: Is it time to revisit ICD indications?	17
Functional tricuspid regurgitation, related right heart remodeling, and available treatment options: good news for patients with heart failure?	17
The role of cardiac magnetic resonance in identifying appropriate candidates for cardiac resynchronization therapy — a systematic review of the literature	17
Heart failure and atrial fibrillation: new concepts in pathophysiology, management, and future directions	17
Subclinical cardiac damage in cancer patients before chemotherapy	16
Letter to the Editor regarding the article “SGLT2 inhibitors and cardiovascular and renal outcomes: a meta‑analysis and trial sequential analysis”	15
Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging	15
The CORolla device for energy transfer from systole to diastole: a novel treatment for heart failure with preserved ejection fraction	15
Sodium-based osmotherapy for hyponatremia in acute decompensated heart failure	15